{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:53:27Z","timestamp":1781877207820,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The international Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend the implementation of a kidney protection strategy (KPS) in patients at high risk of and with Acute Kidney Injury (AKI). However, real-world implementation of this strategy in critically ill patients with AKI is unclear. We quantified timely and sustained adherence to KPS in critically ill adults with moderate-to-severe (KDIGO stage 2 or 3) AKI and explored associations with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a multicenter, prospective cohort study enrolling adult patients with moderate or severe AKI requiring vasopressors and\/or mechanical ventilation across five centers in Europe. The primary endpoint was adherence to the KPS, which included hemodynamic monitoring, sustained optimization of mean arterial pressure (MAP)\u2009&gt;\u200965 mmHg, monitoring of serum creatinine and urine output, and avoidance of hyperglycemia, radiocontrast agents and nephrotoxins when possible, within 12\u00a0h after AKI diagnosis for 48\u00a0h or until ICU discharge. Exploratory analyses examined associations between adherence and renal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 258 patients were enrolled (median age 69 years [IQR 62\u201375]; 65% male; median SOFA 10 [IQR 8\u201313]). The complete KPS was implemented in 80 patients (31%; 95% CI, 25.5\u201337.2%). Adherence to individual components of the KPS varied widely with optimization of MAP showing the lowest implementation rate (33%). In exploratory analyses accounting for death as a competing risk, KPS adherence was associated with a lower incidence of AKD beyond day 7 (subdistribution hazard ratio [SHR] 0.64; 95% CI, 0.41\u20130.99;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046), a higher incidence of renal recovery at hospital discharge (SHR 6.02; 95% CI, 4.00\u20139.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and a lower incidence of RRT within 30 days (SHR 0.12; 95% CI, 0.02\u20130.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). After multivariable adjustment, the association with renal recovery remained robust (adjusted SHR 6.29; 95% CI, 3.08\u201312.85;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). A clear dose-response relationship was observed between the number of implemented KPS components and renal outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In critically ill patients with moderate-to-severe AKI, the complete KDIGO-recommended kidney protection strategy was implemented in approximately one-third of patients, and full KPS adherence was associated with a higher rate of renal recovery at hospital discharge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06144-0","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:54:18Z","timestamp":1781873658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of the kidney protection strategy in critically ill patients with acute kidney injury \u2013 a multi-center prospective cohort study"],"prefix":"10.1186","volume":"30","author":[{"given":"Mahan","family":"Sadjadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Perschinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schauflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Vad\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeq","family":"Husain-Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"Klop-Riehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Booke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig Maximilian","family":"Sch\u00f6ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"von Groote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz J.","family":"Mertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Strau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"6144_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primers. 2021;7:52. https:\/\/doi.org\/10.1038\/s41572-021-00284-z.","journal-title":"Nat Rev Dis Primers"},{"key":"6144_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1164\/rccm.201604-0799OC","volume":"195","author":"JA Kellum","year":"2017","unstructured":"Kellum JA, Sileanu FE, Bihorac A, Hoste EAJ, Chawla LS. Recovery after Acute Kidney Injury. Am J Respir Crit Care Med. 2017;195:784\u201391. https:\/\/doi.org\/10.1164\/rccm.201604-0799OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"6144_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes. New Engl J Med Mass Med Soc. 2014;371:58\u201366. https:\/\/doi.org\/10.1056\/NEJMra1214243.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"6144_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Supplements. 2012;2:1. https:\/\/doi.org\/10.1038\/kisup.2012.1.","journal-title":"Kidney Int Supplements"},{"key":"6144_CR5","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1213\/ANE.0000000000004642","volume":"130","author":"M K\u00fcllmar","year":"2020","unstructured":"K\u00fcllmar M, Wei\u00df R, Ostermann M, Campos S, Grau Novellas N, Thomson G, et al. A Multinational Observational Study Exploring Adherence With the Kidney Disease: Improving Global Outcomes Recommendations for Prevention of Acute Kidney Injury After Cardiac Surgery. Anesth Analgesia. 2020;130:910\u20136. https:\/\/doi.org\/10.1213\/ANE.0000000000004642.","journal-title":"Anesth Analgesia"},{"key":"6144_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","volume":"267","author":"I G\u00f6cze","year":"2018","unstructured":"G\u00f6cze I, Jauch D, G\u00f6tz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann Surg. 2018;267:1013\u201320. https:\/\/doi.org\/10.1097\/SLA.0000000000002485.","journal-title":"Ann Surg"},{"key":"6144_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jtcvs.2019.10.034","volume":"160","author":"DT Engelman","year":"2020","unstructured":"Engelman DT, Crisafi C, Germain M, Greco B, Nathanson BH, Engelman RM, et al. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020;160:1235\u2013e12462. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.034.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6144_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","volume":"43","author":"M Meersch","year":"2017","unstructured":"Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551\u201361. https:\/\/doi.org\/10.1007\/s00134-016-4670-3.","journal-title":"Intensive Care Med"},{"key":"6144_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1213\/ANE.0000000000005458","volume":"133","author":"A Zarbock","year":"2021","unstructured":"Zarbock A, K\u00fcllmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, et al. Prevention of Cardiac Surgery\u2013Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analgesia. 2021;133:292\u2013302. https:\/\/doi.org\/10.1213\/ANE.0000000000005458.","journal-title":"Anesth Analgesia"},{"key":"6144_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01717-9","author":"A Zarbock","year":"2025","unstructured":"Zarbock A, Ostermann M, Forni L, Bode C, Wild L, Putensen C, et al. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial. Lancet [Internet] Elsevier. 2025. https:\/\/doi.org\/10.1016\/S0140-6736(25)01717-9. [cited 2025 Nov 25];0.","journal-title":"Lancet [Internet] Elsevier"},{"key":"6144_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1213\/ANE.0000000000006495","volume":"137","author":"M Sadjadi","year":"2023","unstructured":"Sadjadi M, Porschen C, von Groote T, Albert F, Kellum JA, Gomez H, et al. Implementation of Nephroprotective Measures to Prevent Acute Kidney Injury in Septic Patients: A Retrospective Cohort Study. Anesth Analg. 2023;137:1226\u201332. https:\/\/doi.org\/10.1213\/ANE.0000000000006495.","journal-title":"Anesth Analg"},{"key":"6144_CR12","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLoS Med"},{"key":"6144_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/CCM.0000000000000723","volume":"43","author":"MM Levy","year":"2015","unstructured":"Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015;43:3\u201312. https:\/\/doi.org\/10.1097\/CCM.0000000000000723.","journal-title":"Crit Care Med"},{"key":"6144_CR14","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. New Engl J Med Mass Med Soc. 2017;376:2235\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1703058.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"6144_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"S Uchino","year":"2005","unstructured":"Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813\u20138. https:\/\/doi.org\/10.1001\/jama.294.7.813.","journal-title":"JAMA"},{"key":"6144_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2013.232","volume":"10","author":"JR Prowle","year":"2014","unstructured":"Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37\u201347. https:\/\/doi.org\/10.1038\/nrneph.2013.232.","journal-title":"Nat Rev Nephrol"},{"key":"6144_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1312173.","journal-title":"N Engl J Med"},{"key":"6144_CR18","doi-asserted-by":"publisher","first-page":"R278","DOI":"10.1186\/cc13133","volume":"17","author":"M Legrand","year":"2013","unstructured":"Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz A-C, et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care Lond Engl. 2013;17:R278. https:\/\/doi.org\/10.1186\/cc13133.","journal-title":"Crit Care Lond Engl"},{"key":"6144_CR19","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1681\/ASN.2014070724","volume":"26","author":"JA Kellum","year":"2015","unstructured":"Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by Urine Output versus Serum Creatinine Level. J Am Soc Nephrol. 2015;26:2231\u20138. https:\/\/doi.org\/10.1681\/ASN.2014070724.","journal-title":"J Am Soc Nephrol"},{"key":"6144_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.chest.2017.05.011","volume":"152","author":"K Jin","year":"2017","unstructured":"Jin K, Murugan R, Sileanu FE, Foldes E, Priyanka P, Clermont G, et al. Intensive Monitoring of Urine Output Is Associated With Increased Detection of Acute Kidney Injury and Improved Outcomes. Chest. 2017;152:972\u20139. https:\/\/doi.org\/10.1016\/j.chest.2017.05.011.","journal-title":"Chest"},{"key":"6144_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449\u201361. https:\/\/doi.org\/10.1056\/NEJMoa052521.","journal-title":"N Engl J Med"},{"key":"6144_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813\u201320. https:\/\/doi.org\/10.1038\/414813a.","journal-title":"Nature"},{"key":"6144_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1056\/NEJMra1805256","volume":"380","author":"R Mehran","year":"2019","unstructured":"Mehran R, Dangas GD, Weisbord SD. Contrast-Associated Acute Kidney Injury. N Engl J Med. 2019;380:2146\u201355. https:\/\/doi.org\/10.1056\/NEJMra1805256.","journal-title":"N Engl J Med"},{"issue":"4","key":"6144_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000007075","volume":"54","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026;54(4):725\u2013812. https:\/\/doi.org\/10.1097\/CCM.0000000000007075.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06144-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:13:19Z","timestamp":1781874799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06144-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6144"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06144-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Research Ethics Committee of the Chamber of Physicians, Westfalen-Lippe, and the University of M\u00fcnster (2023-708-f-S). Written informed consent was obtained from all participants or their legal representatives per local regulations and the ethics committee requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AZ has received consulting fees from Astute-Biomerieux, Baxter, Dropshot, Revelation, Bayer, Novartis, Guard Therapeutics, Chugai, AM Pharma, Paion, Viatris and Fresenius, research funding from Astute-Biomerieux, Fresenius, and Baxter, and speaker fees from Astute-Biomerieux, Paion, Viatris, Fresenius, and Baxter. JAK has received consulting fees from AstraZeneca, Bayer, Baxter, bioM\u00e9rieux, Chugai Pharma, and Mitsubishi Tenabe. GV has received consulting fees from Baxter and Vantive. PP has received travel and consultation reimbursements from Baxter\/Vantive, AmPharma, SphingoTec, EBI, and 4Teen4. MJ has received grants from Baxter\/Vantive and Fresenius, consulting fees from Baxter\/Vantive, AmPharma, Biomerieux, SphingoTec and Novartis as well as lecture fees from Baxter, Biomerieux and AOP, and is board member of the International Society of Critical Care Nephrology (ISCCN). All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}